OpenVSafe by OpenVAERS
Search V-safe

YYQ-21840-74299

3 vaccinations 2 coded responses 5 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
588 / ND
Registered
2021-05-21
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-21
    Registered in v-safe
  3. 2021-05-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-05-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-06-10
    Dose 2 — Pfizer-BioNTech
  6. 2022-03-01
    Dose 3 — Pfizer-BioNTech
  7. 2022-05-20
    Health check-in — 12 months, dose 1
    Feeling: Good
    Adult check-in
  8. 2022-09-01
    Survey response — 6 months, dose 3
    MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Covid + tested
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-09-01
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  10. 2022-09-02
  11. 2023-03-01
    Survey response — 12 months, dose 3
    MedDRA: Malaise — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  12. 2023-03-01
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2023-03-02
  14. 2023-03-02

Vaccinations

DoseDateManufacturerCo-administered
12021-05-20Pfizer-BioNTech
22021-06-10Pfizer-BioNTech No
32022-03-01Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-09-01 Unsuccessful
2023-03-01 Unsuccessful

Free text

Release 12 — 6 months, dose 3

2022-09-01

Symptoms: Covid + tested

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMalaise · · ✓
SDSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…